XHKG
8357
Market cap14mUSD
Oct 07, Last price
0.18HKD
1D
-0.54%
1Q
38.35%
IPO
-72.94%
Name
Republic Healthcare Ltd
Chart & performance
P/E
—
P/S
2.39
EPS
—
Div yield, %
—
Shrs. gr., 5y
3.71%
Rev. gr., 5y
-10.80%
Revenues
8m
-15.00%
Net income
-3m
L+1,563.70%
CFO
-2m
L
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Republic Healthcare Limited, a Singaporean primary healthcare enterprise, furnishes an array of medical services, encompassing consultations, diagnostic examinations, and therapeutic interventions. The company delivers diverse treatment solutions for prevalent health issues, specifically prioritizing sexual health and infectious diseases. Furthermore, it provides remedies for common dermatological ailments and basic medical aesthetics. The organization manages ten clinics in total: nine branded as Dr. Tan & Partners, alongside a single S Aesthetics clinic. Founded in 2010, Republic Healthcare Limited conducts its operations from its headquarters situated in Singapore.
Key people
Cher Sen Tan
Executive Chairman of the Board, Compliance Officer · since 2020
Chee Heng Tan
Financial Controller
Chun Pong Tang
Company Secretary · since 2021
Liang Wang
Non-Executive Director · since 2025
Lee Ngo Kang
Lead Independent Non-Executive Director · since 2025
Yee Leong Wong
Independent Non-Executive Director · since 2022
Teck Chuan Yeo
Independent Non-Executive Director · since 2021
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||